Stock Should Be $10 By Xmas Here's Why
This is why the stock should be trading at $10:
Ray said in the conference call: "Parenthetically, it has hardly escaped our notice that during the past quarter, Bristol Myers has paid $2.1 billion dollars for the HALF, that would be HALF, of the melanoma drug from Medarax that they did not already own, a drug known as Ipilimumab, also a compound that is pre-data."
He made sure that he noted, TWICE, that Bristol Myers paid a whopping $2.1 BILLION for only HALF of a drug...that DID NOT EVEN HAVE DATA!!! ... WE ARE GOING TO HAVE DATA BY VETERANS DAY, and Ray said that they have suspended Genasense talks until the data is out!!
He WOULDN'T have hinted at this if it meant nothing...
$2.1 Billion dollar market cap at 133.7 million shares = $15.70
(even if you thought the dilution would make it DOUBLE the outstanding shares, its still an $8 stock based on the potential sale price of Genasense alone)
If you don't get it, I'm implying that a WORSE drug that LACKED the data that we have, was purchased for 2.1 Billion$...and that was only HALF of what it was worth.
So if Genasense get's purchased...even only have...it should be LARGER than 2.1 Billion in CASH...and that ALONE would propel us over 15$ at this many outstanding shares....
So Ray was implying that our BETTER Genasense drug would sell for MORE than 2.1 Billion for half....
So if you factor NO OTHER INFORMATION from the company, and just the cash that they would get in a BAD deal for Genasense...that's 2.1 Billion dollar market cap.
This thing is going to explode, eventually. Basically Ray just said bidding starts at $2.1 Billion dollars once the data comes out. And that SEC filing said that the financial decision for the company would be out 14 days after the public announcement of AGENDA results.
